Knowledge Center
Article / Aug 01, 2014
Pharmaceutical Manufacturing and Supply-Chain Trends to 2020
Source:
Pharmaceutical Technology Europe, August 2014
A breach in the pharmaceutical supply chain is only the tip of the iceberg.
Innovators (Big Pharma and biotech companies) are today a minority player supplying only about 20% of the world’s medicines. At present, the vast majority of medicines are generic—the fruits of the best science of the 20th century can now be enjoyed for a few cents a pill.
Related links
Also in the Knowledge Center
/ Jan 01, 2012
Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions
Read more
Scientific Article
/ Jan 01, 2012
Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
Read more
Scientific Article
Scientific Article